BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 28912261)

  • 1. Preoperative Pectoralis Muscle Quantity and Attenuation by Computed Tomography Are Novel and Powerful Predictors of Mortality After Left Ventricular Assist Device Implantation.
    Teigen LM; John R; Kuchnia AJ; Nagel EM; Earthman CP; Kealhofer J; Martin C; Cogswell R
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Model Incorporating Pectoralis Muscle Measures to Predict Mortality After Ventricular Assist Device Implantation.
    Cogswell R; Trachtenberg B; Murray T; Schultz J; Teigen L; Allen T; Araujo-Gutierrez R; John R; Martin CM; Estep J
    J Card Fail; 2020 Apr; 26(4):308-315. PubMed ID: 31770634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation.
    Topilsky Y; Oh JK; Shah DK; Boilson BA; Schirger JA; Kushwaha SS; Pereira NL; Park SJ
    JACC Cardiovasc Imaging; 2011 Mar; 4(3):211-22. PubMed ID: 21414567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Long Term Outcome in Patients Treated With Continuous Flow Left Ventricular Assist Device: The Penn-Columbia Risk Score.
    Birati EY; Hanff TC; Maldonado D; Grandin EW; Kennel PJ; Mazurek JA; Vorovich E; Seigerman M; Howard JLL; Acker MA; Naka Y; Wald J; Goldberg LR; Jessup M; Atluri P; Margulies KB; Schulze PC; Rame JE
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29514805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart Failure Severity Stratification Beyond INTERMACS Profiles: A Step Toward Optimal Left Ventricular Assist Device Timing.
    Cogswell R; Estep JD; Araujo-Gutierrez R; Masotti M; Majaraj V; Teigen L; Schultz J; John R; Martin CM; Trachtenberg B
    ASAIO J; 2021 May; 67(5):554-560. PubMed ID: 33470635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of tricuspid repair at the time of left ventricular assist device implantation and survival.
    Brewer RJ; Cabrera R; El-Atrache M; Zafar A; Hrobowski TN; Nemeh HM; Selektor Y; Paone G; Williams CT; Velez M; Tita C; Morgan JA; Lanfear DE
    Int J Artif Organs; 2014 Nov; 37(11):834-8. PubMed ID: 25450319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR
    Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation.
    Imamura T; Chung B; Nguyen A; Rodgers D; Sayer G; Adatya S; Sarswat N; Kim G; Raikhelkar J; Ota T; Song T; Juricek C; Kagan V; Jeevanandam V; Mehra M; Burkhoff D; Uriel N
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-Year Clinical Outcome in End-Stage Heart Failure: Comparison of "High Urgent" Listing for Heart Transplantation with Mechanical Circulatory Support Implantation.
    Sunavsky J; Zittermann A; Oezpeker C; Fujita B; Fuchs U; Gummert JF; Schulz U
    Thorac Cardiovasc Surg; 2015 Dec; 63(8):647-52. PubMed ID: 26177226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients.
    Brenyo A; Rao M; Koneru S; Hallinan W; Shah S; Massey HT; Chen L; Polonsky B; McNitt S; Huang DT; Goldenberg I; Aktas M
    J Cardiovasc Electrophysiol; 2012 May; 23(5):515-20. PubMed ID: 22081967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac Resynchronization Therapy and Clinical Outcomes in Continuous Flow Left Ventricular Assist Device Recipients.
    Gopinathannair R; Roukoz H; Bhan A; Ravichandran A; Ahmed MM; Familtsev D; Bhat G; Cowger J; Abdullah M; Sandesara C; Dhawan R; Birks EJ; Trivedi JR; Slaughter MS
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29907652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pump replacement on outcome in advanced heart failure patients with left ventricular assist system.
    Iwashima Y; Yanase M; Horio T; Seguchi O; Murata Y; Fujita T; Toda K; Kawano Y; Nakatani T
    Artif Organs; 2013 Jul; 37(7):606-14. PubMed ID: 23692322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-operative sarcopenia is predictive of recurrent gastrointestinal bleeding on left ventricular assist device support: A multicenter analysis.
    Klajda M; Trachtenberg B; Araujo R; Estep JD; Masotti M; Teigen L; Schultz J; John R; Martin C; Suarez EE; Cogswell R
    J Heart Lung Transplant; 2022 Jun; 41(6):757-762. PubMed ID: 35105490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
    Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged continuous-flow left ventricular assist device support and posttransplantation outcomes: A new challenge.
    Fukuhara S; Takeda K; Polanco AR; Takayama H; Naka Y
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):872-880.e5. PubMed ID: 26896362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant valve procedures in patients undergoing continuous-flow left ventricular assist device implantation: A single-center experience.
    Sugiura T; Kurihara C; Kawabori M; Critsinelis AC; Wang S; Civitello AB; Rosengart TK; Frazier OH; Morgan JA
    J Thorac Cardiovasc Surg; 2019 Oct; 158(4):1083-1089.e1. PubMed ID: 30904255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent risk factors for ICU mortality after left ventricular assist device implantation.
    Piffard M; Nubret-Le Coniat K; Simon O; Leuillet S; Rémy A; Barandon L; Ouattara A
    Artif Organs; 2020 Feb; 44(2):153-161. PubMed ID: 31318978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Diabetes Mellitus on Outcomes in Patients Supported With Left Ventricular Assist Devices: A Single Institutional 9-Year Experience.
    Asleh R; Briasoulis A; Schettle SD; Tchantchaleishvili V; Pereira NL; Edwards BS; Clavell AL; Maltais S; Joyce DL; Joyce LD; Daly RC; Kushwaha SS; Stulak JM
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of Serum Cholesterol Predicts Survival After Left Ventricular Assist Device Implantation.
    Vest AR; Kennel PJ; Maldonado D; Young JB; Mountis MM; Naka Y; Colombo PC; Mancini DM; Starling RC; Schulze PC
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.